Background Maternal rectovaginal colonization with group B Streptococcus (GBS) is the
most common pathway for GBS disease in mother, fetus, and newborn. This article, the …

Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Background We aimed to provide the first comprehensive estimates of the burden of group B
Streptococcus (GBS), including invasive disease in pregnant and postpartum women, fetal …

Summary Background Group B streptococcus (GBS) is a major cause of invasive disease in
young infants. Infants born to women with sufficient pre-existing anti-GBS capsular IgG …

Background Preterm birth complications are the leading cause of deaths among children< 5
years of age. Studies have suggested that group B Streptococcus (GBS) maternal …

Background 21 million pregnant women worldwide (18%) are estimated to carry Group B
Streptococcus (GBS), which is a risk for invasive disease in newborns, pregnant women …

Background There are an estimated 2.6 million stillbirths each year, many of which are due
to infections, especially in low-and middle-income contexts. This paper, the eighth in a …

Streptococcus agalactiae, or group B streptococcus (GBS), is a major neonatal pathogen.
Recent data have elucidated the global prevalence of maternal and neonatal colonization …

Improving maternal, newborn, and child health is central to Sustainable Development Goal
targets for 2030, requiring acceleration especially to prevent 5.6 million deaths around the …

Abstract Globally, group B Streptococcus (GBS) remains a leading cause of sepsis and
meningitis in infants in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for …